Spots Global Cancer Trial Database for invasive carcinoma

Every month we try and update this database with for invasive carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery	NCT04955808	Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin...	Biospecimen Col... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
X-Ray Mammography Standard of Care Protocol	NCT01052740	Breast Cancer Invasive Carcin... In Situ Carcino... Fibrocystic Cha... Atypical Ductal...		18 Years - 100 Years	National Institutes of Health Clinical Center (CC)
Fast Spectral Imaging Device for Tumor Margin Mapping	NCT01107080	Breast Cancer		18 Years -	Duke University
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	NCT03676101	Cervical Cancer... Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 AIS Invasive Carcin... Mild Dysplasia ... Moderate Dyspla... Vin III VaIN1 VaIN2 VaIN3 Genital Wart	9-valent HPV Re... Placebo	9 Years - 45 Years	Shanghai Bovax Biotechnology Co., Ltd.
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery	NCT04955808	Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin...	Biospecimen Col... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma	NCT03534947	Basal Cell Carc... Basal Cell Carc... Skin Cancer Invasive Carcin...	Sonidegib Imiquimod Surgery Best supportive...	18 Years -	Melanoma Institute Australia
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)	NCT02363829	Uterine Cervix ...	Nelfinavir Cisplatin	18 Years -	Abramson Cancer Center at Penn Medicine
Fast Spectral Imaging Device for Tumor Margin Mapping	NCT01107080	Breast Cancer		18 Years -	Duke University
Therapeutic Nipple Sparing Mastectomy.	NCT02311959	Breast Cancer	Nipple sparing ...	40 Years -	Institut Claudius Regaud
X-Ray Mammography Standard of Care Protocol	NCT01052740	Breast Cancer Invasive Carcin... In Situ Carcino... Fibrocystic Cha... Atypical Ductal...		18 Years - 100 Years	National Institutes of Health Clinical Center (CC)
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	NCT03676101	Cervical Cancer... Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 AIS Invasive Carcin... Mild Dysplasia ... Moderate Dyspla... Vin III VaIN1 VaIN2 VaIN3 Genital Wart	9-valent HPV Re... Placebo	9 Years - 45 Years	Shanghai Bovax Biotechnology Co., Ltd.
To Evaluate the Characteristics of a Breast Cancer	NCT01055678	Breast Cancer	EF5 Partial or Tota...	18 Years -	Duke University
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)	NCT02363829	Uterine Cervix ...	Nelfinavir Cisplatin	18 Years -	Abramson Cancer Center at Penn Medicine

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: